FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199675843> ?p ?o ?g. }

• W3199675843 endingPage "e003311" @default.
• W3199675843 startingPage "e003311" @default.
• W3199675843 abstract "Modulation of adaptive immunity may underscore the efficacy of trans-arterial chemoembolization (TACE). We evaluated the influence of TACE on T-cell function by phenotypic lymphocyte characterization in samples of patients undergoing surgery with (T+) or without (T-) prior-TACE treatment.We profiled intratumoral (IT), peritumoral (PT) and non-tumoral (NT) background tissue to evaluate regulatory CD4+/FOXP3+ (T-reg) and immune-exhausted CD8+/PD-1+ T-cells across T+ (n=58) and T- (n=61). We performed targeted transcriptomics and T-cell receptor sequencing in a restricted subset of samples (n=24) evaluated in relationship with the expression of actionable drivers of anti-cancer immunity including PD-L1, indoleamine 2,3 dehydrogenase (IDO-1), cytotoxic T-lymphocyte associated protein 4 (CTLA-4), Lag-3, Tim-3 and CD163.We analyzed 119 patients resected (n=25, 21%) or transplanted (n=94, 79%) for Child-Pugh A (n=65, 55%) and Barcelona Clinic Liver Cancer stage A (n=92, 77%) hepatocellular carcinoma. T+ samples displayed lower IT CD4+/FOXP3+ (p=0.006), CD8+ (p=0.002) and CD8+/PD-1+ and NT CD8+/PD-1+ (p<0.001) compared with T-. Lower IT (p=0.005) and NT CD4+/FOXP3+ (p=0.03) predicted for improved recurrence-free survival. In a subset of samples (n=24), transcriptomic analysis revealed upregulation of a pro-inflammatory response in T+. T+ samples were enriched for IRF2 expression (p=0.01), an interferon-regulated transcription factor implicated in cancer immune-evasion. T-cell clonality and expression of PD-L1, IDO-1, CTLA-4, Lag-3, Tim-3 and CD163 was similar in T+ versus T-.TACE is associated with lower IT density of immune-exhausted effector cytotoxic and T-regs, with significant upregulation of pro-inflammatory pathways. This highlights the pleiotropic effects of TACE in modulating the tumor microenvironment and strengthens the rationale for developing immunotherapy alongside TACE." @default.
• W3199675843 created "2021-09-27" @default.
• W3199675843 creator A5001343667 @default.
• W3199675843 creator A5001483790 @default.
• W3199675843 creator A5001737873 @default.
• W3199675843 creator A5004158910 @default.
• W3199675843 creator A5004783631 @default.
• W3199675843 creator A5007542328 @default.
• W3199675843 creator A5009824484 @default.
• W3199675843 creator A5014172694 @default.
• W3199675843 creator A5020147308 @default.
• W3199675843 creator A5037515641 @default.
• W3199675843 creator A5038518740 @default.
• W3199675843 creator A5045113980 @default.
• W3199675843 creator A5045203407 @default.
• W3199675843 creator A5051870259 @default.
• W3199675843 creator A5064169322 @default.
• W3199675843 creator A5064470324 @default.
• W3199675843 creator A5067431043 @default.
• W3199675843 creator A5067464504 @default.
• W3199675843 creator A5067785572 @default.
• W3199675843 creator A5077300644 @default.
• W3199675843 creator A5083761306 @default.
• W3199675843 date "2021-09-01" @default.
• W3199675843 modified "2023-10-14" @default.
• W3199675843 title "Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy." @default.
• W3199675843 cites W1779771004 @default.
• W3199675843 cites W1975154077 @default.
• W3199675843 cites W1988684186 @default.
• W3199675843 cites W1989565979 @default.
• W3199675843 cites W1992523229 @default.
• W3199675843 cites W1996345468 @default.
• W3199675843 cites W2011663359 @default.
• W3199675843 cites W2019432440 @default.
• W3199675843 cites W2023369016 @default.
• W3199675843 cites W2039959838 @default.
• W3199675843 cites W2043070331 @default.
• W3199675843 cites W2047055395 @default.
• W3199675843 cites W2052683874 @default.
• W3199675843 cites W2052730188 @default.
• W3199675843 cites W2111616718 @default.
• W3199675843 cites W2115289723 @default.
• W3199675843 cites W2115450250 @default.
• W3199675843 cites W2123469465 @default.
• W3199675843 cites W2131758491 @default.
• W3199675843 cites W2145760497 @default.
• W3199675843 cites W2153932922 @default.
• W3199675843 cites W2155106513 @default.
• W3199675843 cites W2277004004 @default.
• W3199675843 cites W2286222994 @default.
• W3199675843 cites W2546700240 @default.
• W3199675843 cites W2606367731 @default.
• W3199675843 cites W2609400849 @default.
• W3199675843 cites W2661307008 @default.
• W3199675843 cites W2739338441 @default.
• W3199675843 cites W2755693293 @default.
• W3199675843 cites W2771488404 @default.
• W3199675843 cites W2791328450 @default.
• W3199675843 cites W2805592007 @default.
• W3199675843 cites W2883204623 @default.
• W3199675843 cites W2923548794 @default.
• W3199675843 cites W2946663348 @default.
• W3199675843 cites W2964961256 @default.
• W3199675843 cites W2970242544 @default.
• W3199675843 cites W2977722669 @default.
• W3199675843 cites W2990602950 @default.
• W3199675843 cites W2996066981 @default.
• W3199675843 cites W2999444423 @default.
• W3199675843 cites W3004910654 @default.
• W3199675843 cites W3006976136 @default.
• W3199675843 cites W3012211502 @default.
• W3199675843 cites W3013242650 @default.
• W3199675843 cites W3025022288 @default.
• W3199675843 cites W3111942073 @default.
• W3199675843 cites W3138484572 @default.
• W3199675843 doi "https://doi.org/10.1136/jitc-2021-003311" @default.
• W3199675843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8487214" @default.
• W3199675843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34593621" @default.
• W3199675843 hasPublicationYear "2021" @default.
• W3199675843 type Work @default.
• W3199675843 sameAs 3199675843 @default.
• W3199675843 citedByCount "50" @default.
• W3199675843 countsByYear W31996758432022 @default.
• W3199675843 countsByYear W31996758432023 @default.
• W3199675843 crossrefType "journal-article" @default.
• W3199675843 hasAuthorship W3199675843A5001343667 @default.
• W3199675843 hasAuthorship W3199675843A5001483790 @default.
• W3199675843 hasAuthorship W3199675843A5001737873 @default.
• W3199675843 hasAuthorship W3199675843A5004158910 @default.
• W3199675843 hasAuthorship W3199675843A5004783631 @default.
• W3199675843 hasAuthorship W3199675843A5007542328 @default.
• W3199675843 hasAuthorship W3199675843A5009824484 @default.
• W3199675843 hasAuthorship W3199675843A5014172694 @default.
• W3199675843 hasAuthorship W3199675843A5020147308 @default.
• W3199675843 hasAuthorship W3199675843A5037515641 @default.
• W3199675843 hasAuthorship W3199675843A5038518740 @default.
• W3199675843 hasAuthorship W3199675843A5045113980 @default.
• W3199675843 hasAuthorship W3199675843A5045203407 @default.

• next